Aurobindo Pharma receives USFDA Approval for Entecavir Tablets
Entecavir tablets are used to treat hepatitis B infection.
Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Entecavir Tablets, 0.5mg and 1mg.
IMS data suggest, entecavir has an estimated market size of $294 million for the 12 months ending June 2015.
The company has now a total of 209 ANDA approvals from the US FDA.
entecavir approval.pdf (74.9 KB)
| Subscribe To Our Free Newsletter |
